Skip to content
HowShorted

bluebird bio, Inc. short interest in 2019

In 2019, bluebird bio, Inc.'s disclosed short interest ran from 9.13% of shares outstanding on 15 Jan 2019 to 15.46% on 31 Dec 2019, a change of +6.33 percentage points. The year's high was 16.20% on 30 Sep 2019 and its low 9.13% on 15 Jan 2019, averaging 12.69% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.13 days on 30 Aug 2019. Full history: bluebird bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for bluebird bio, Inc. in 2019

2019 in figures

Start of year
9.13% (15 Jan 2019)
End of year
15.46% (31 Dec 2019)
Change
+6.33 pp
High
16.20% (30 Sep 2019)
Low
9.13% (15 Jan 2019)
Average
12.69%
Highest days to cover
15.13 (30 Aug 2019)
SEC filings marked
8

Every report in 2019

bluebird bio, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20199.13%8.69
31 Jan 20199.68%7.75
15 Feb 20199.75%14.60
28 Feb 20199.87%7.4910-K filed, results (8-K)
15 Mar 20199.42%9.25
29 Mar 20199.36%13.17
15 Apr 20199.76%12.54
30 Apr 20199.34%9.07
15 May 20199.42%9.7010-Q filed, results (8-K)
31 May 201910.03%14.61
14 Jun 201911.42%12.71
28 Jun 201914.57%9.37
15 Jul 201913.54%14.00
31 Jul 201913.58%14.54
15 Aug 201914.81%13.4810-Q filed, results (8-K)
30 Aug 201915.29%15.13
13 Sep 201915.79%14.67
30 Sep 201916.20%12.28
15 Oct 201916.12%10.27
31 Oct 201915.91%13.4810-Q filed, results (8-K)
15 Nov 201915.96%7.25
29 Nov 201914.69%5.50
13 Dec 201915.56%4.89
31 Dec 201915.46%7.41

See also: bluebird bio, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.